Inhibition of the in vitro 19S and 7S antibody response by immunoglobulin-binding factor (IBF) from alloantigen-activated T cells |
| |
Authors: | Roland H. Gisler Wolf H. Fridman |
| |
Affiliation: | 1. Research Department, Pharmaceuticals Division, Ciba-Geigy Limited, 4002-Basel, Switzerland;1. Laboratoire d''Immunologie des Tumeurs, INSERM U 136 Hôpital Saint-Louis, 75010 Paris, France |
| |
Abstract: | A soluble factor secreted by alloantigen-activated mouse T cells which binds to the Fc fragment of IgG and inhibits complement activation by IgG (immunoglobulin-binding factor, IBF) suppressed the in vitro 19S and 7S antibody response by mouse spleen cells to T-dependent as well as T-independent antigens. IBF inhibited the 19S plaque response best when it was added late during PFC generation (between 48 and 72 hr). On the other hand, when it was left in cultures for up to 60 hr and then removed, antibody synthesis was not inhibited. However, its presence for only 2 hr starting after 72 hr of incubation was sufficient to inhibit PFC formation. The suppressive activity of IFB could be neutralized by adding aggregated mouse IgG prior to the critical stage around 72 hr. These data favour the view that IBF could be a suppressive T cell factor and point to the possibility that IBF may act on already triggered B cells during their final differentiation to active PFC. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|